These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30078546)

  • 1. [Integrated podiatrist care for prostate cancer patients treated with docetaxel: Feasibility and results].
    Chabanol H; Huillard O; Prin L; Villeminey C; Rondeau A; Boudou-Rouquette P; Astorg F; Musenghesi B; Du Mortier C; Alexandre J; Goldwasser F
    Bull Cancer; 2018 Dec; 105(12):1173-1182. PubMed ID: 30078546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
    Scotté F; Banu E; Medioni J; Levy E; Ebenezer C; Marsan S; Banu A; Tourani JM; Andrieu JM; Oudard S
    Cancer; 2008 Apr; 112(7):1625-31. PubMed ID: 18286527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-induced nail dystrophy.
    Nicolopoulos J; Howard A
    Australas J Dermatol; 2002 Nov; 43(4):293-6. PubMed ID: 12423438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subungueal haemorrhages following docetaxel (taxotere) treatment.
    Fenniche S; Hammami H; Badri T; Mokhtar I; Benmously R
    Curr Drug Saf; 2012 Jul; 7(3):247-9. PubMed ID: 22950986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.
    Scotté F; Tourani JM; Banu E; Peyromaure M; Levy E; Marsan S; Magherini E; Fabre-Guillevin E; Andrieu JM; Oudard S
    J Clin Oncol; 2005 Jul; 23(19):4424-9. PubMed ID: 15994152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.
    Roh MR; Cho JY; Lew W
    Yonsei Med J; 2007 Feb; 48(1):124-6. PubMed ID: 17326255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nails with bloodstained discoloration.
    Gregoriou S; Platsidaki E; Sidiropoulou P; Rigopoulos D
    BMJ; 2021 Oct; 375():n1951. PubMed ID: 34645604
    [No Abstract]   [Full Text] [Related]  

  • 8. A rare manifestation of nail changes with docetaxel therapy.
    Halvorson CR; Erickson CL; Gaspari AA
    Skinmed; 2010; 8(3):179-80. PubMed ID: 21137627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity.
    Kushnir I; Koczka K; Ong M; Canil C; Bossé D; Sabri E; Reaume MN
    Med Oncol; 2019 Jan; 36(2):18. PubMed ID: 30666463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel induced hemorrhagic onycholysis.
    Narayan R V; Subburaj K; Mahajan R
    Dermatol Ther; 2022 Aug; 35(8):e15578. PubMed ID: 35536595
    [No Abstract]   [Full Text] [Related]  

  • 11. Nail toxicity induced by cancer chemotherapy.
    Gilbar P; Hain A; Peereboom VM
    J Oncol Pharm Pract; 2009 Sep; 15(3):143-55. PubMed ID: 19171552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic management for taxane-induced nail toxicity: A systematic review and meta-analysis.
    Huang KL; Lin KY; Huang TW; Loh EW; Hua YM; Su HC; Tam KW
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13118. PubMed ID: 31184794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel-induced nail toxicity: a case of severe onycholysis and topic review.
    Lau CP; Hui P; Chan TC
    Chin Med J (Engl); 2011 Aug; 124(16):2559-60. PubMed ID: 21933605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel-induced palmoplantar erythrodysesthesia syndrome and long-lasting multiple nail changes.
    Akoglu G
    Indian J Pharmacol; 2014; 46(2):225-7. PubMed ID: 24741199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild Cryotherapy for Prevention of Paclitaxel-Induced Nail Toxicity in Breast Cancer Patients: A Phase II Single-Arm Clinical Trial.
    Mazzega-Fabbro C; Polesel J; Spazzapan S; Meneghetti L; Montagner D; Tabaro G; Bartoletti M; Puglisi F
    Clin Breast Cancer; 2023 Jun; 23(4):447-453. PubMed ID: 36997403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective randomized controlled trial of hydrating nail solution for prevention or treatment of onycholysis in breast cancer patients who received neoadjuvant/adjuvant docetaxel chemotherapy.
    Kim JY; Ok ON; Seo JJ; Lee SH; Ahn JS; Im YH; Park YH
    Breast Cancer Res Treat; 2017 Aug; 164(3):617-625. PubMed ID: 28488142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
    Can G; Aydiner A; Cavdar I
    Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases.
    Ben Nasr S; Zribi A; Ben Hassen M; Doghri Y; Ben Abdallah I; Trigui E; Fendri S; Ayari J; Balti M; Haddaoui A
    Bull Cancer; 2021 Mar; 108(3):266-271. PubMed ID: 33423777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail changes secondary to docetaxel (Taxotere).
    Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
    Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onycholysis associated with weekly administration of paclitaxel.
    Flory SM; Solimando DA; Webster GF; Dunton CJ; Neufeld JM; Haffey MB
    Ann Pharmacother; 1999 May; 33(5):584-6. PubMed ID: 10369623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.